Ligand profile
NDG
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: A0A075B6I6
Identifiers
Database identifiers and provenance.
- Ligand ID
NDG- PDB
2fd6- UniProt (similar protein)
Q52L64- Target protein
- A0A075B6I6
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 119.3
- −1 ≤ LogP ≤ 5 -3.08
- MW ≤ 500 Da 221.2
- LogP ≤ 5 -3.08
- H-bond donors ≤ 5 5
- H-bond acceptors ≤ 10 6
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 119.3
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@@H]1O)CO)O)OCC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@@H]1O)CO)O)O
InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6-,7-,8+/m1/s1InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6-,7-,8+/m1/s1
OVRNDRQMDRJTHS-PVFLNQBWSA-NOVRNDRQMDRJTHS-PVFLNQBWSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ domain
- Source
- PDB
- Binding sites
- PF00021
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand NDG →
- PDB RCSB structure 2fd6 →
- UniProt UniProt Q52L64 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “NDG”) →
Other ligands for this protein
Quick navigation to other ligands bound to A0A075B6I6.
PDB 54
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 29
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).